Neptune at Health Ingredient Europe 2006 in Frankfurt
Thursday, October 26 2006

Neptune at Health Ingredient Europe 2006 in Frankfurt

While at Health Ingredient Europe 2006 on November 14-16, come and visit us at the Canadian Pavilion, booth E 6003.

Don't miss the show case session on NKO!

When: Tuesday, November 14, 2006 at 10:30 - 11:00

Where: Messe Frankfurt GmbH, Hall 3.0 Exhibitor floor, Ludwig-Erhard-Anlage 1, 60327 Frankfurt a. M.

Title: NKO™ Nature’s Health Choice

Topic: Summary of the clinical outcomes of NKO™ on lipids inflammation and cognitive function

Author: Dr. Tina Sampalis - Vice President in Research and Business Development – Neptune Technologies and Bioressources

Hi Europe 2006 - Show Case information
http://www.hi-events.com/content/Programme14-11.aspx

It will be a great pleasure to see you there!

Neither NASDAQ nor TSX venture exchange accepts responsibility for the adequacy or accuracy of this press release.
Neptune Technologies and Acasti Pharma Contact:
Neptune Technologies & Bioressources Inc.
Acasti Pharma Inc.
Toni Rinow, Ph.D., MBA
Corporate Development & Investor Relations
(450) 687-2262
This e-mail address is being protected from spambots, you need JavaScript enabled to view it
# # #
Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of the Company to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "expects," "intends," "anticipates," "will," or "plans" to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's reports filed with the Securities and Exchange Commission and the Canadian securities commissions.
 

We communicate

NTB (TSX) CAN$ 1.93 +0.03
NEPT (NASDAQ) US$ 1.898 +0.068
 

press releases

Investor Relations Contact NEPTUNE TECHNOLOGIES & BIORESSOURCES